Immutep's Stock Price And Volume Action
Immutep's IMMP stock is trading up 51.71% to a price of $3.87. Thursday the stock has been traded at a volume of 36.98 million, about 5962.91% of its recent 30-day volume average of 620.23 thousand.
Why It's Moving
Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: Immutep, F-star Gain On Positive News On Rival's Candidate: Immutep, an Australian biotech that develops immunotherapies for cancer and autoimmune disorders, and U.K.-based F-star, a clinical-stage biopharma developing tetravalent bispecific antibodies for cancer treatment, are reacting to a positive readout from Bristol-Myers Squibb BMY.
Perspective On Recent Price Action
The stock's 50-day moving average was $3.01 at the time this article was published. Over the past fifty-two weeks, the price has risen as high as $7.95 and fallen to a low of $0.53.
Benzinga Pro provides investors with timely and accurate explanations of why a stock is moving. Subscribe to receive real-time alerts explaining stock price movements. Click here to learn more.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.